AstraZeneca
AZN
#61
Rank
NZ$474.67 B
Marketcap
NZ$306.07
Share price
0.73%
Change (1 day)
25.67%
Change (1 year)

P/S ratio for AstraZeneca (AZN)

P/S ratio as of June 2026 (TTM): 4.55

According to AstraZeneca's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.64. At the end of 2026 the company had a P/S ratio of 4.83.

P/S ratio history for AstraZeneca from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20264.83-1.39%
20254.9030.16%
20243.77-17.53%
20234.57-3.75%
20224.74-2.19%
20214.85-1.45%
20204.92-8.31%
20195.3725.56%
20184.2710.21%
20173.8829.36%
20163.00-14.32%
20153.503.59%
20143.3817.2%
20132.8837.53%
20122.1016.3%
20111.80-7.89%
20101.96-5.78%
20092.0810.47%
20081.88-10.96%
20072.11-31.88%
20063.10-4.92%
20053.2616.72%
20042.79-35.74%
20034.3527.15%
20023.42-1.11%
20013.46

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
5.89 29.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5.11 12.37%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.34-48.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3.42-24.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
13.9 206.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.89-58.44%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
2.95-35.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
4.31-5.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.37-47.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2.37-47.87%๐Ÿ‡ฌ๐Ÿ‡ง UK